| Thursday, April 4, 2013 |
| |
Patria Hall |
Bartok Hall |
| 08:30-09:00 |
Welcome followed by Special Lecture |
|
|
| 09:00-10:20 |
Debate Session 1: Bone oriented therapies with focus on biologics |
Oral Session 1: Autoimmune diseases |
|
| 10:20-11:00 |
Innovative forms in rheumatology: Satellite Symposium supported by Sager Pharma |
| 11:00-11:20 |
Coffee Break, Exhibition and Poster Session 1 |
| 11:20-12:40 |
Debate Session 3: Uncoupling of inflammation and destruction in arthritides |
Debate Session 2: Scleroderma: is there any treatment for skin and internal organs? |
| 12:40-13:40 |
Lunch Break, Exhibition and Poster Session 1 |
Parallel Poster Walks 1 and 2 |
| 13:40-15:00 |
Debate Session 4: Inflammatory myopathies: is it all the same? |
Oral Session 2: Arthritis and treatment I |
|
| 15:00-15:45 |
Key findings on CT-P13 of its comparability to Infliximab - Satellite Symposium supported by EGIS-Celltrion |
|
| 15:45-16:15 |
Coffee Break, Exhibition and Poster Session 1 |
| 16:15-17:35 |
Debate Session 5: Are infections pathogenic or protective in autoimmunity? |
Debate Session 6: Are epigenetics or genetics more important in the pathogenesis of arthritides? |
|
| 17:45-18:30 |
Keynote Lecture - Vitamin D in autoimmunity: myth or reality? |
|
|
| 18:30 |
Opening Ceremony & Welcome Reception |
|
| |
|
|
| Friday, April 5, 2013 |
| |
Patria Hall |
Bartok Hall |
| 08:30-09:50 |
Debate Session 7: What is the future of targeted therapy: biologics or small molecules? |
Debate Session 8: Do we need manual or automated tests of ANA immunofluorescence? |
| 09:50-10:30 |
Oral Session 3: Uveitis |
Oral Session 4: Diagnostics |
| 10:30-11:00 |
Gout, new drugs - Satellite Symposium supported by Berlin Chemie - Menarini |
| 11:00-11:30 |
Coffee Break, Exhibition and Poster Session 2 |
| 11:30-12:50 |
Debate Session 9: SLE: what is the effective treatment if any? |
Debate Session 10: Which are better: laboratory biomarkers or imaging in the diagnostics of arthritides? |
| 12:50-13:20 |
Biotechnology at Gedeon Richter – new options in the future medical treatment - Satellite Symposium supported by Gedeon Richter |
|
| 13:20-14:20 |
Lunch Break, Exhibition and Poster Session 2 |
| |
13:50-14:50
Parallel Poster Walks 3, 4 and 5 |
| 14:20-14:50 |
Abatacept: earlier lines and long term efficacy in RA - Satellite Symposium supported by BMS |
| 14:50-16:10 |
Debate Session 11: Biologics and vascular disease, cancer |
Debate Session 12: Is there any evidence for balneotherapy in the treatment of rheumatic diseases? |
| 16:10-16:40 |
Coffee Break, Exhibition and Poster Session 2 |
| 16:40-18:10 |
Primum non nocere: Pregnancy, autoimmune disease and immunotherapy - Session supported by UCB Pharma |
Oral Session 5:
Pathogenisis and Artherosclerosis |
| 18:10-19:10 |
Surprise Lecture |
|
| |
|
|
| Saturday, April 6, 2013 |
| |
Patria Hall |
Bartok Hall |
| 08:30-09:50 |
Debate Session 13: Early start and stop of biologics: has the time come? |
Debate Session 14: Is atherosclerosis an autoimmune disease? |
| 09:50-10:50 |
New targets in rheumatology - Satellite Symposium supported by Pfizer |
Oral Session 6: Arthritis and Treatment II |
| 10:50-11:10 |
Knowns and unknowns on biosimilar monoclonal antibodies - Satellite Symposium supported by MSD Pharma Hungary |
| 11:10-11:40 |
Coffee Break and Exhibition |
| 11:40-13:00 |
Debate Session 15: Antiphospholipid syndrome: what are the major controversies? |
Debate Session 16: Do animal models resemble human arthritis or not? |
| 13:00-13:30 |
Closing Ceremony & Awards |
|